Ahmad Rima, Setia Namrata, Schmidt Benjamin H, Hong Theodore S, Wo Jennifer Y, Kwak Eunice L, Rattner David W, Lauwers Gregory Y, Mullen John T
Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Yawkey 7B, Boston, MA, 02114, USA.
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
J Gastrointest Surg. 2016 Mar;20(3):531-8. doi: 10.1007/s11605-015-2945-6. Epub 2015 Sep 18.
The application of endoscopic and local resection for early gastric cancer (EGC) is limited by the risk of regional lymph node (LN) metastasis. We sought to determine the incidence and predictors of LN metastasis in a contemporary cohort of Western patients with early gastric cancer.
Sixty-seven patients with pT1 gastric adenocarcinoma underwent radical surgery without neoadjuvant therapy at our institution between 1995 and 2011, and clinicopathologic factors predicting LN metastasis were analyzed.
LN metastases were present in 15/67 (22 %) pT1 tumors, including 1/23 (4 %) T1a tumors and 14/44 (32 %) T1b tumors. Tumor size, site, degree of differentiation, macroscopic tumor sub-classification, perineural invasion status, and depth of submucosal tumor penetration did not predict LN metastasis. The presence of lymphovascular invasion (LVI) and positive nodal status by endoscopic ultrasound (EUS) were the only factors that predicted LN metastasis on multivariate analysis. T1a tumors without LVI had a 0 % rate of positive LN, whereas T1b tumors with LVI had a 64.3 % rate of positive LN.
EGC limited to the mucosa, without evidence of LVI, and N0 on EUS, may be considered for limited resection. However, any EGC with submucosal invasion, LVI, or positive nodes on EUS should undergo radical resection with lymphadenectomy.
早期胃癌(EGC)内镜及局部切除的应用受区域淋巴结(LN)转移风险限制。我们试图确定当代西方早期胃癌患者队列中LN转移的发生率及预测因素。
1995年至2011年间,67例pT1期胃腺癌患者在我院接受了无新辅助治疗的根治性手术,并对预测LN转移的临床病理因素进行了分析。
15/67(22%)例pT1期肿瘤存在LN转移,其中1/23(4%)例T1a期肿瘤和14/44(32%)例T1b期肿瘤发生转移。肿瘤大小、部位、分化程度、大体肿瘤亚分类、神经侵犯状态及黏膜下肿瘤浸润深度均不能预测LN转移。多因素分析显示,仅存在脉管侵犯(LVI)及内镜超声(EUS)检查提示淋巴结阳性是预测LN转移的因素。无LVI的T1a期肿瘤LN阳性率为0%,而有LVI的T1b期肿瘤LN阳性率为64.3%。
局限于黏膜层、无LVI证据且EUS检查为N0的EGC可考虑行局限性切除。然而,任何伴有黏膜下浸润、LVI或EUS检查提示淋巴结阳性的EGC均应行根治性切除及淋巴结清扫术。